soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Effects of on in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized Oral Semaglutide and Cardiovascular Outcomes

CagriSema FDA Approval Status

They were discovered in the early 20th century, but their applications in age-related diseases are relatively recent, with a number of studies increasing steadily since the early 2000s

Oral Semaglutide Side Effects As with all medications, oral semaglutide can cause side effects, though most are mild to moderate and tend to improve over time

Neuroendocrine normalization: Studies in aged animal models document normalized anterior pituitary function and restored luteinizing hormone and follicle-stimulating hormone pulsatility following administration

If you have any questions or feedback about what youve read, you can reach out to us at [email protected]